Global Platelet Rich Plasma Market Segmentation, By Type (Pure Platelet Rich Plasma, Leukocyte-Rich Platelet Rich Plasma, Leukocyte-Rich Fibrin, Others), Origin (Allogeneic Platelet Rich Plasma, Autologous Platelet Rich Plasma, Homologous Platelet Rich Plasma), Application (Cosmetic Surgery and Aesthetics, General Surgery, Neurosurgery, Orthopedic and Spinal Surgery, Others), End User (Hospitals and Clinics, Research Institutes, Others) - Industry Trends and Forecast to 2031.
Platelet Rich Plasma Market Analysis
Platelet rich plasma has been widely used in clinical settings in recent years. It has gained a lot of traction in the world of cosmetic surgery. Plastic surgeons and dermatologists are using platelets' natural healing properties to improve the appearance and overall health of the skin. Several research studies have evaluated the use of Platelet Rich Plasma for facial rejuvenation, with positive aesthetic outcomes.
Platelet Rich Plasma Market Size
Global platelet rich plasma market size was valued at USD 677.88 million in 2023 and is projected to reach USD 1739.30 million by 2031, with a CAGR of 12.5% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Platelet Rich Plasma Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Ycellbio Medical Co., Ltd. (South Korea), Zimmer Biomet (US), Stryker Corporation (US), ROCKY MOUNTAIN BIOLOGICALS (US), Regen Lab SA (Switzerland), TERUMO BCT, INC. (US), GLOFINN (Finland), ExaTech Inc. (US), EmCyte Corporation(US), ThermoGenesis Holdings, Inc. (US), Octapharma Brasil Ltda (Brazil), Dr PRP USA LLC (US), Isto Biologics (US), Arthrex, Inc. (US), Terumo Corporation (Japan), Cascade Medical. (US), Grifols, S.A. (Spain), Johnson & Johnson Private Limited (US)
|
|
Market Opportunities
|
|
Platelet Rich Plasma Market Definition
Blood is used to create platelet rich plasma (PRP). It is created when human blood is spun down and platelet rich plasma with platelet concentrations above normal values is separated. Platelets aid in blood clotting and the healing of tendons, muscles, and ligaments.
Platelet Rich Plasma Market Dynamics
Drivers
Major factors that are expected to boost the growth of the platelet rich plasma market in the forecast period are as follows:
- Rise in the prevalence of sports injuries
Sports-related injuries have increased over the last two decades. Knee, elbow, and shoulder injuries are the most common sports injuries in softball and baseball players which will further accelerate the market growth.
- Growing number of cosmetic surgical procedures
The number of cosmetic surgical procedures performed has increased over the last five years, as has people's preference for minimally invasive cosmetic surgery. Liposuction and facelifts are becoming increasingly popular which is further anticipated to propel the growth of the platelet rich plasma market.
- Technological developments
Technological advancements in platelet rich plasma devices, which have led to an increase in the use of pure platelet rich plasma in various situations and high platelet concentration. The industry has also benefited from technological breakthroughs such as smart home diagnostic kits which is expected to drive the market.
Opportunities
In addition, the rise in the in the awareness related platelet rich plasma therapies is further estimated to provide potential opportunities for the growth of the platelet rich plasma market in the coming years.
Restraints/Challenges
On the other hand, the increased volatilization in the price of platelet-rich plasma therapy is further projected to impede the growth of the platelet rich plasma market in the targeted period. However, the difficulties regarding the quality control and test results might further challenge the growth of the platelet rich plasma market in the near future.
This platelet rich plasma market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the platelet rich plasma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Platelet Rich Plasma Market
The pandemic of COVID-19 has had a huge impact on the platelet rich plasma market. The unexpected outbreak has had a positive impact on market growth. Due to a lack of antiviral therapies and the fact that plasma therapy is considered an emergency treatment method, the COVID-19 pandemic has helped to expand the market. One of the advantages of platelet-rich plasma is that it can be used to relieve pain during COVID-19. However, in the post-COVID scenario, there is a growing demand for platelet rich plasma.
Platelet Rich Plasma Market Scope and Market Size
The platelet rich plasma market is segmented on the basis of type, origin, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Pure Platelet Rich Plasma
- Leukocyte-Rich Platelet Rich Plasma
- Leukocyte-Rich Fibrin
- Others
On the basis of type, the platelet rich plasma market is segmented into pure platelet rich plasma, leukocyte-rich platelet rich plasma, leukocyte-rich fibrin and others.
Origin
- Allogeneic Platelet Rich Plasma
- Autologous Platelet Rich Plasma
- Homologous Platelet Rich Plasma
On the basis of origin, the platelet rich plasma market is segmented into allogeneic platelet rich plasma, autologous platelet rich plasma and homologous platelet rich plasma.
Application
- Cosmetic Surgery and Aesthetics
- General Surgery
- Neurosurgery
- Orthopedic and Spinal Surgery
- Others
On the basis of application, the platelet rich plasma market is segmented into cosmetic surgery and aesthetics, general surgery, neurosurgery, orthopedic and spinal surgery and others. Others have been further sub segmented into urology, cardiothoracic surgery, oral and maxillofacial surgery, periodontal surgery, otorhinolaryngology-head and neck surgery.
End user
- Hospitals and Clinics
- Research Institutes
- Others
On the basis of end user, the platelet rich plasma market is segmented into hospitals, and clinics, research institutes and others.
Platelet Rich Plasma Market Regional Analysis
The platelet rich plasma market is analysed and market size insights and trends are provided by country, type, origin, application and end user as referenced above.
The countries covered in the platelet rich plasma market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the platelet rich plasma market due to the rise in the incidence of chronic disorders. Furthermore, the well-settled healthcare infrastructure will further boost the growth of the platelet rich plasma market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the platelet rich plasma market due to the increase in the government support. Moreover, the rise in the elderly population will further boost the growth of the platelet rich plasma market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Platelet Rich Plasma Market Share Analysis
The platelet rich plasma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to platelet rich plasma market.
Platelet Rich Plasma Market Leaders Operating in the Market Are::
- Ycellbio Medical Co., Ltd. (South Korea)
- Zimmer Biomet (US)
- Stryker Corporation (US)
- ROCKY MOUNTAIN BIOLOGICALS (US)
- Regen Lab SA (Switzerland)
- TERUMO BCT, INC. (US)
- GLOFINN (Finland)
- ExaTech Inc. (US)
- EmCyte Corporation(US)
- ThermoGenesis Holdings, Inc. (US)
- Octapharma Brasil Ltda (Brazil)
- Dr PRP USA LLC (US)
- Isto Biologics (US)
- Arthrex, Inc. (US)
- Terumo Corporation (Japan)
- Cascade Medical. (US)
- Grifols, S.A. (Spain)
- Johnson & Johnson Private Limited (US)
SKU-